Doximity (DOCS) to Release Quarterly Earnings on Thursday

Doximity (NASDAQ:DOCS) is scheduled to issue its quarterly earnings data after the market closes on Thursday, November 7th. Analysts expect the company to announce earnings of $0.26 per share for the quarter. Doximity has set its FY 2025 guidance at EPS and its Q2 2025 guidance at EPS.Parties that wish to listen to the company’s conference call can do so using this link.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.06. The business had revenue of $126.68 million during the quarter, compared to the consensus estimate of $119.88 million. Doximity had a return on equity of 19.26% and a net margin of 32.53%. On average, analysts expect Doximity to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Doximity Stock Up 0.2 %

NASDAQ:DOCS opened at $41.98 on Thursday. Doximity has a twelve month low of $19.89 and a twelve month high of $44.88. The stock’s 50-day simple moving average is $40.44 and its 200 day simple moving average is $32.15. The firm has a market capitalization of $7.79 billion, a PE ratio of 52.48, a price-to-earnings-growth ratio of 5.29 and a beta of 1.29.

Wall Street Analysts Forecast Growth

Several brokerages recently issued reports on DOCS. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target on the stock in a report on Friday, August 9th. Robert W. Baird upped their price target on shares of Doximity from $41.00 to $45.00 and gave the stock an “outperform” rating in a report on Tuesday, September 17th. Morgan Stanley increased their price target on Doximity from $26.00 to $33.00 and gave the company an “underweight” rating in a research note on Wednesday. Bank of America boosted their price objective on Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a research report on Monday, October 7th. Finally, Canaccord Genuity Group increased their target price on Doximity from $37.00 to $40.00 and gave the company a “buy” rating in a research report on Tuesday, August 20th. Two analysts have rated the stock with a sell rating, seven have given a hold rating, five have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $36.42.

Insider Activity at Doximity

In other Doximity news, Director Watkin Phoebe L. Yang sold 1,011 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The shares were sold at an average price of $25.54, for a total transaction of $25,820.94. Following the completion of the transaction, the director now owns 11,258 shares in the company, valued at approximately $287,529.32. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, CFO Anna Bryson sold 30,000 shares of the business’s stock in a transaction dated Friday, August 9th. The stock was sold at an average price of $35.00, for a total value of $1,050,000.00. Following the transaction, the chief financial officer now directly owns 309,627 shares of the company’s stock, valued at $10,836,945. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of the firm’s stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the sale, the director now directly owns 11,258 shares of the company’s stock, valued at $287,529.32. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 37.40% of the stock is currently owned by company insiders.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.